Search for: "Sandoz, Inc"
Results 41 - 60
of 680
Sorted by Relevance
|
Sort by Date
22 Nov 2010, 1:24 pm
Karst – Sandoz Inc. [read post]
10 Aug 2017, 9:58 pm
" trilogy of BPCIA Federal Circuit cases, the Court in Amgen Inc. v. [read post]
12 Feb 2015, 11:27 am
Sandoz, Inc., 135 S.Ct. 831, 841 (2015); id. [read post]
29 Jul 2014, 12:08 pm
The reference product, Neupogen®, which brought maker Amgen Inc. $1.4 billion in sales in 2013, is a biologic used […] [read post]
26 Mar 2015, 9:59 pm
Sandoz may be relevant in cases that are the exception rather than the rule. [read post]
17 Oct 2018, 7:49 pm
Sandoz Inc., October 12, 2018, Reyna, J.). [read post]
29 Oct 2008, 4:53 am
Sandoz By Kevin E. [read post]
20 Oct 2011, 11:46 pm
On September 28, Bayer won a dismissal of U.S. antitrust claims that were made against it by Sandoz Inc. [read post]
6 May 2013, 4:33 pm
On May 1, the US Court of Appeals for the Federal Circuit issued an interesting, yet controversial, ruling in Allergan Inc. v Sandoz Inc. et Al., examining obviousness in the context of a combination ophthalmic drug treatment. [read post]
10 Feb 2013, 8:54 am
Sandoz Inc. 3:13-cv-00733; filed February 5, 2013 in the District Court of New Jersey • Plaintiffs: Cadence Pharmaceuticals, Inc.; SCR Pharmatop • Defendant: Sandoz Inc. [read post]
7 Jul 2020, 9:15 am
Sandoz, Inc., Sandoz International GMBH, Sandoz GMBH, holding that Sandoz failed to prove that the asserted claims were invalid for obviousness-type double patenting (ODP), failure to meet the written description requirement, and obviousness for lack of motivation to combine... [read post]
9 Jan 2016, 6:00 pm
Sandoz Inc. that an "appellate court must apply a 'clear error,' not de novo, standard of review" to the evidentiary underpinnings of a district court's claim construction determination. [read post]
19 May 2016, 8:56 pm
• Defendants: Sandoz Inc.; Sandoz International GmbH; Sandoz GmbH; Lek Pharmaceuticals, d.d. [read post]
11 Jul 2016, 9:59 pm
Sandoz case. [read post]
10 Jun 2010, 9:46 pm
By James DeGiulio -- Endo Settles with Impax and Sandoz in Opana Patent Suits Endo Pharmaceuticals Inc. has settled patent infringement suits against Sandoz Inc. and Impax Laboratories Inc. over generic versions of painkiller Opana ER. [read post]
28 Jan 2015, 10:00 pm
Sandoz, Inc. [read post]
21 Jul 2015, 8:27 am
”); TRW Inc. v. [read post]
23 Aug 2022, 8:52 pm
Sandoz Inc. (2015)"). [read post]
29 Jan 2013, 9:21 pm
Barr Laboratories, Inc., interesting. [read post]
2 Jan 2015, 8:30 am
Indianapolis, Indiana - In conjunction with co-counsel, an Indiana patent attorney for Eli Lilly and Company of Indianapolis, Indiana sued in the Southern District of Indiana alleging infringement by Sandoz Inc. of Princeton, New Jersey of ALIMTA®, Patent No. 7,772,209, which was issued by the U.S. [read post]
